Atlas Trials

Role of Alpha-to-beta Cell Communication to Adapt Insulin Secretion to Insulin Resistance.

Clinical trial NCT07224334 · RECRUITING

Trial details

NCT number
NCT07224334
Sponsor
David D'Alessio, M.D.
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Diabetes (DM)
Start date
2025-12-30
Primary completion
2027-12-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.